Evaluation of Indeterminate Liver Lesions (LR-3 and LR-4)
The Liver Imaging Reporting and Data System (LI-RADS) standardizes imaging interpretation for liver lesions. Our group has a particular interest in indeterminate liver lesions (LI-RADS-3 and LR-4), which present challenges in clinical decision-making. We have led studies characterizing their natural history, including risk of developing HCC, and defined recommended management algorithms. As a site in the Translational Liver Cancer Consortium (TLC), we are prospectively enrolling patients with LR-3 and LR-4 patients to evaluate blood- and imaging-based strategies for risk stratification and early detection of HCC.